News

Breaking News

Home / NPR / Eli Lilly Ends Coronavirus Antibody Treatment Trial, Other Studies Go On

Eli Lilly Ends Coronavirus Antibody Treatment Trial, Other Studies Go On


In this May 2020 file photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. On Monday, U.S. government officials announced they are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn

The trial studied the efficacy of bamlanivimab and remdesivir on hospitalized COVID-19 patients - the same therapies given to President Trump. But researchers say people showed no marked improvement.

(Image credit: David Morrison/AP)

https://ift.tt/2m0CM10

BEST MOBILES ON 40% DISCOUNTS

BEST MOBILES ON 40% DISCOUNTS
BEST MOBILES ON DISCOUNTS